A citation-based method for searching scientific literature

Amit V Khera, Connor A Emdin, Isabel Drake, Pradeep Natarajan, Alexander G Bick, Nancy R Cook, Daniel I Chasman, Usman Baber, Roxana Mehran, Daniel J Rader, Valentin Fuster, Eric Boerwinkle, Olle Melander, Marju Orho-Melander, Paul M Ridker, Sekar Kathiresan. N Engl J Med 2016
Times Cited: 584







List of co-cited articles
585 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
32

Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
Michael Inouye, Gad Abraham, Christopher P Nelson, Angela M Wood, Michael J Sweeting, Frank Dudbridge, Florence Y Lai, Stephen Kaptoge, Marta Brozynska, Tingting Wang,[...]. J Am Coll Cardiol 2018
304
23


Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
J L Mega, N O Stitziel, J G Smith, D I Chasman, M Caulfield, J J Devlin, F Nordio, C Hyde, C P Cannon, F Sacks,[...]. Lancet 2015
370
19

Clinical use of current polygenic risk scores may exacerbate health disparities.
Alicia R Martin, Masahiro Kanai, Yoichiro Kamatani, Yukinori Okada, Benjamin M Neale, Mark J Daly. Nat Genet 2019
691
19

Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.
Joshua Elliott, Barbara Bodinier, Tom A Bond, Marc Chadeau-Hyam, Evangelos Evangelou, Karel G M Moons, Abbas Dehghan, David C Muller, Paul Elliott, Ioanna Tzoulaki. JAMA 2020
142
17

Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease.
Jonathan D Mosley, Deepak K Gupta, Jingyi Tan, Jie Yao, Quinn S Wells, Christian M Shaffer, Suman Kundu, Cassianne Robinson-Cohen, Bruce M Psaty, Stephen S Rich,[...]. JAMA 2020
125
16

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.
Pradeep Natarajan, Robin Young, Nathan O Stitziel, Sandosh Padmanabhan, Usman Baber, Roxana Mehran, Samantha Sartori, Valentin Fuster, Dermot F Reilly, Adam Butterworth,[...]. Circulation 2017
237
15

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
14

The UK Biobank resource with deep phenotyping and genomic data.
Clare Bycroft, Colin Freeman, Desislava Petkova, Gavin Band, Lloyd T Elliott, Kevin Sharp, Allan Motyer, Damjan Vukcevic, Olivier Delaneau, Jared O'Connell,[...]. Nature 2018
14

UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
Cathie Sudlow, John Gallacher, Naomi Allen, Valerie Beral, Paul Burton, John Danesh, Paul Downey, Paul Elliott, Jane Green, Martin Landray,[...]. PLoS Med 2015
13

The personal and clinical utility of polygenic risk scores.
Ali Torkamani, Nathan E Wineinger, Eric J Topol. Nat Rev Genet 2018
566
12

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
Nina Mars, Jukka T Koskela, Pietari Ripatti, Tuomo T J Kiiskinen, Aki S Havulinna, Joni V Lindbohm, Ari Ahola-Olli, Mitja Kurki, Juha Karjalainen, Priit Palta,[...]. Nat Med 2020
113
12

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.
Donald M Lloyd-Jones, Yuling Hong, Darwin Labarthe, Dariush Mozaffarian, Lawrence J Appel, Linda Van Horn, Kurt Greenlund, Stephen Daniels, Graham Nichol, Gordon F Tomaselli,[...]. Circulation 2010
11


2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Donna K Arnett, Roger S Blumenthal, Michelle A Albert, Andrew B Buroker, Zachary D Goldberger, Ellen J Hahn, Cheryl Dennison Himmelfarb, Amit Khera, Donald Lloyd-Jones, J William McEvoy,[...]. Circulation 2019
10

Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.
Hayato Tada, Olle Melander, Judy Z Louie, Joseph J Catanese, Charles M Rowland, James J Devlin, Sekar Kathiresan, Dov Shiffman. Eur Heart J 2016
153
10

Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Krishna G Aragam, Amanda Dobbyn, Renae Judy, Mark Chaffin, Kumardeep Chaudhary, George Hindy, Andrew Cagan, Phoebe Finneran, Lu-Chen Weng, Ruth J F Loos,[...]. J Am Coll Cardiol 2020
43
23

Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
Salim S Virani, Alvaro Alonso, Hugo J Aparicio, Emelia J Benjamin, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Susan Cheng, Francesca N Delling,[...]. Circulation 2021
10

Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups.
Ozan Dikilitas, Daniel J Schaid, Matthew L Kosel, Robert J Carroll, Christopher G Chute, Joshua A Denny, Alex Fedotov, QiPing Feng, Hakon Hakonarson, Gail P Jarvik,[...]. Am J Hum Genet 2020
45
20

Genomic prediction of coronary heart disease.
Gad Abraham, Aki S Havulinna, Oneil G Bhalala, Sean G Byars, Alysha M De Livera, Laxman Yetukuri, Emmi Tikkanen, Markus Perola, Heribert Schunkert, Eric J Sijbrands,[...]. Eur Heart J 2016
166
9

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
Amy Damask, P Gabriel Steg, Gregory G Schwartz, Michael Szarek, Emil Hagström, Lina Badimon, M John Chapman, Catherine Boileau, Sotirios Tsimikas, Henry N Ginsberg,[...]. Circulation 2020
80
11

Towards clinical utility of polygenic risk scores.
Samuel A Lambert, Gad Abraham, Michael Inouye. Hum Mol Genet 2019
169
9

Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
Iftikhar J Kullo, Hayan Jouni, Erin E Austin, Sherry-Ann Brown, Teresa M Kruisselbrink, Iyad N Isseh, Raad A Haddad, Tariq S Marroush, Khader Shameer, Janet E Olson,[...]. Circulation 2016
144
8

A decade of genome-wide association studies for coronary artery disease: the challenges ahead.
Jeanette Erdmann, Thorsten Kessler, Loreto Munoz Venegas, Heribert Schunkert. Cardiovasc Res 2018
151
8

Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.
Nicholas A Marston, Frederick K Kamanu, Francesco Nordio, Yared Gurmu, Carolina Roselli, Peter S Sever, Terje R Pedersen, Anthony C Keech, Huei Wang, Armando Lira Pineda,[...]. Circulation 2020
78
10

Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction.
Amit V Khera, Mark Chaffin, Seyedeh M Zekavat, Ryan L Collins, Carolina Roselli, Pradeep Natarajan, Judith H Lichtman, Gail D'Onofrio, Jennifer Mattera, Rachel Dreyer,[...]. Circulation 2019
120
8

Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.
Satoshi Koyama, Kaoru Ito, Chikashi Terao, Masato Akiyama, Momoko Horikoshi, Yukihide Momozawa, Hiroshi Matsunaga, Hirotaka Ieki, Kouichi Ozaki, Yoshihiro Onouchi,[...]. Nat Genet 2020
64
12

Next-generation genotype imputation service and methods.
Sayantan Das, Lukas Forer, Sebastian Schönherr, Carlo Sidore, Adam E Locke, Alan Kwong, Scott I Vrieze, Emily Y Chew, Shawn Levy, Matt McGue,[...]. Nat Genet 2016
8

The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation.
Samuel A Lambert, Laurent Gil, Simon Jupp, Scott C Ritchie, Yu Xu, Annalisa Buniello, Aoife McMahon, Gad Abraham, Michael Chapman, Helen Parkinson,[...]. Nat Genet 2021
89
8

Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels.
Yixuan Ye, Xi Chen, James Han, Wei Jiang, Pradeep Natarajan, Hongyu Zhao. Circ Genom Precis Med 2021
22
36

Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants.
Loes Ca Rutten-Jacobs, Susanna C Larsson, Rainer Malik, Kristiina Rannikmäe, Cathie L Sudlow, Martin Dichgans, Hugh S Markus, Matthew Traylor. BMJ 2018
88
9

Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.
Minxian Wang, Ramesh Menon, Sanghamitra Mishra, Aniruddh P Patel, Mark Chaffin, Deepak Tanneeru, Manjari Deshmukh, Oshin Mathew, Sanika Apte, Christina S Devanboo,[...]. J Am Coll Cardiol 2020
28
25

Principal components analysis corrects for stratification in genome-wide association studies.
Alkes L Price, Nick J Patterson, Robert M Plenge, Michael E Weinblatt, Nancy A Shadick, David Reich. Nat Genet 2006
7

Improving reporting standards for polygenic scores in risk prediction studies.
Hannah Wand, Samuel A Lambert, Cecelia Tamburro, Michael A Iacocca, Jack W O'Sullivan, Catherine Sillari, Iftikhar J Kullo, Robb Rowley, Jacqueline S Dron, Deanna Brockman,[...]. Nature 2021
94
7

A common variant on chromosome 9p21 affects the risk of myocardial infarction.
Anna Helgadottir, Gudmar Thorleifsson, Andrei Manolescu, Solveig Gretarsdottir, Thorarinn Blondal, Aslaug Jonasdottir, Adalbjorg Jonasdottir, Asgeir Sigurdsson, Adam Baker, Arnar Palsson,[...]. Science 2007
6

Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
Florian Wünnemann, Ken Sin Lo, Alexandra Langford-Avelar, David Busseuil, Marie-Pierre Dubé, Jean-Claude Tardif, Guillaume Lettre. Circ Genom Precis Med 2019
34
17

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
6


2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
6


Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
Joseph Yeboah, Robyn L McClelland, Tamar S Polonsky, Gregory L Burke, Christopher T Sibley, Daniel O'Leary, Jeffery J Carr, David C Goff, Philip Greenland, David M Herrington. JAMA 2012
715
6

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.
Akl C Fahed, Minxian Wang, Julian R Homburger, Aniruddh P Patel, Alexander G Bick, Cynthia L Neben, Carmen Lai, Deanna Brockman, Anthony Philippakis, Patrick T Ellinor,[...]. Nat Commun 2020
104
6

Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Bjarni J Vilhjálmsson, Jian Yang, Hilary K Finucane, Alexander Gusev, Sara Lindström, Stephan Ripke, Giulio Genovese, Po-Ru Loh, Gaurav Bhatia, Ron Do,[...]. Am J Hum Genet 2015
571
6


Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
Rainer Malik, Ganesh Chauhan, Matthew Traylor, Muralidharan Sargurupremraj, Yukinori Okada, Aniket Mishra, Loes Rutten-Jacobs, Anne-Katrin Giese, Sander W van der Laan, Solveig Gretarsdottir,[...]. Nat Genet 2018
570
6

Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population.
Anna Fry, Thomas J Littlejohns, Cathie Sudlow, Nicola Doherty, Ligia Adamska, Tim Sprosen, Rory Collins, Naomi E Allen. Am J Epidemiol 2017
991
6


A common allele on chromosome 9 associated with coronary heart disease.
Ruth McPherson, Alexander Pertsemlidis, Nihan Kavaslar, Alexandre Stewart, Robert Roberts, David R Cox, David A Hinds, Len A Pennacchio, Anne Tybjaerg-Hansen, Aaron R Folsom,[...]. Science 2007
5

Genomewide association analysis of coronary artery disease.
Nilesh J Samani, Jeanette Erdmann, Alistair S Hall, Christian Hengstenberg, Massimo Mangino, Bjoern Mayer, Richard J Dixon, Thomas Meitinger, Peter Braund, H-Erich Wichmann,[...]. N Engl J Med 2007
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.